Evaluation of Clinical Outcomes and Costs Based on Prescribed Dose Level of Renin-Angiotensin-Aldost
Advertisement
Advertisement
Trending on AJMC
1
Moderna, Merck mRNA Cancer Vaccine Succeeds in Late-Stage Trial
2
Trump Expected to Select White House Aide Heidi Overton to Lead FDA
3
Waist Size, Not Just Weight, Predicts Mortality Risk in Older Adults
4
Vutrisiran Associated With Slower Decline in Left Atrial Function in ATTR-CM
5